Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
复制标题
DOI:
10.1371/journal.pone.0264489
复制
发表时间:
2022
期刊:
影响因子:
3.7
通讯作者:
O'Connor KC
中科院分区:
文献类型:
--
作者:
Fichtner ML;Hoarty MD;Vadysirisack DD;Munro-Sheldon B;Nowak RJ;O'Connor KC
Acetylcholine receptor (AChR) autoantibodies, found in patients with autoimmune myasthenia gravis (MG), can directly contribute to disease pathology through activation of the classical complement pathway. Activation of the complement pathway in autoimmune diseases can lead to a secondary complement deficiency resulting in reduced complement activity, due to consumption, during episodes of disease activity. It is not clear whether complement activity in MG patients associates with measurements of disease activity or the titer of circulating pathogenic AChR autoantibodies. To explore such associations, as a means to identify a candidate biomarker, we measured complement activity in AChR MG samples (N = 51) using a CH50 hemolysis assay, then tested associations between these values and both clinical status and AChR autoantibody titer. The majority of the study subjects (88.2%) had complement activity within the range defined by healthy controls, while six patients (11.8%) showed reduced activity. No significant association between complement activity and disease status or AChR autoantibody titer was observed.
登录
查看更多内容
影响因子:
11
作者:
BEHAN, WMH;BEHAN, PO
通讯作者:
BEHAN, PO
影响因子:
11
作者:
LEFVERT, AK;BERGSTROM, K;PIRSKANEN, R
通讯作者:
PIRSKANEN, R
影响因子:
9.9
作者:
ENGEL, AG;SAKAKIBARA, H;LENNON, VA
通讯作者:
LENNON, VA
影响因子:
7.3
作者:
da Costa, Mariana Gaya;Poppelaars, Felix;Seelen, Marc A.
通讯作者:
Seelen, Marc A.
影响因子:
3.1
作者:
Machimoto, Takafumi;Guerra, Giselle;Scornik, Juan
通讯作者:
Scornik, Juan